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Abstract
Background: In the search for new therapies novel drugs and medications are being discovered, developed and
tested in laboratories. Highly diluted substances are intended to enhance immune system responses resulting in
reduced frequency of various diseases, and often present no risk of serious side-effects due to its low toxicity. Over
the past years our research group has been investigating the action of highly diluted substances and tinctures on
cells from the immune system.
Methods: We have developed and tested several highly diluted tinctures and here we describe the biological
activity of M1, M2, and M8 both in vitro in immune cells from mice and human, and in vivo in mice. Cytotoxicity,
cytokines released and NF-B activation were determined after in vitro treatment. Cell viability, oxidative response,
lipid peroxidation, bone marrow and lymph node cells immunophenotyping were accessed after mice in vivo
treatment.
Results: None of the highly diluted tinctures tested were cytotoxic to macrophages or K562. Lipopolysaccharide
(LPS)-stimulated macrophages treated with all highly diluted tinctures decreased tumour necrosis factor alpha
(TNF-a) release and M1, and M8 decreased IFN-g production. M1 has decreased NF-B activity on TNF-a stimulated
reporter cell line. In vivo treatment lead to a decrease in reactive oxygen species (ROS), nitric oxide (NO)
production was increased by M1, and M8, and lipid peroxidation was induced by M1, and M2. All compounds
enhanced the innate immunity, but M1 also augmented acquired immunity and M2 diminished B lymphocytes,
responsible to acquired immunity.
Conclusions: Based on the results presented here, these highly diluted tinctures were shown to modulate
immune responses. Even though further investigation is needed there is an indication that these highly diluted
tinctures could be used as therapeutic interventions in disorders where the immune system is compromised.
Keywords: drug discovery, highly diluted tinctures, immune cells, bone marrow cells, lymph node cells,
macrophages
Background
Highly diluted substances and tinctures are usually
intended to enhance the immune system resulting in
reduced frequency of various diseases. The immune sys-
tem is a complex network that integrates lymphoid
organs, cells, humoral factors, and cytokines. The essen-
tial function of the immune system is host defense, but
when it does not work properly the disease emerges.
For instance, underactivity may result in severe infec-
tions and tumors of immunodeficiency, overactivity in
allergic and autoimmune disease [1]. When the body
successfully fights any potential harmfully agent by itself
it results in an enhancement of the immune system.
Conventional treatments often are directed to terminate
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the symptoms rather than fighting the disease cause,
and frequently present side effects. Adverse drug reac-
tions inflict serious injury to million people around the
world. It is known that all substances can produce
harmful effects associated with its toxic properties, and
quoting Paracelsus (1493-1541) “all substances are poi-
sons; there is none which is not a poison. The right
dose differentiates a poison”. The search for effective
treatments with low toxicity to patient is needed.
Changes in the dose could be effective in order to
diminish the harmful side effects. All drugs present a
dose response curve, or a range of doses that result in a
graded effect between the extremes of no effect and
100% response which is the toxic effect. If the dose is
low enough even a highly toxic substance will cease to
cause the harmful effect on biological systems. Thus in
the case of using highly diluted compounds or tinctures
you might avoid the harmful effects as it often present
no risk of serious side-effects because of their low toxi-
city, and still obtain an effective response such as modu-
lation of the immune system.
Over the past years our research group has been test-
ing the action of highly diluted substances and tinctures
on cells from the immune system [2-4]. The develop-
ment of new combinations was based on laboratorial
tests and assays were performed independently and in a
blind manner. These were crucial to determine which
substances to use on each combination of highly diluted
tinctures. For instance, one substance when used alone
presents modification in biological responses, i.e. it
increases cytokine production by cells, but when com-
bined to another substance the effects on biological
responses are annulled (data not published yet). Biologi-
cal assays are intended to understand better what hap-
pens within a cell when a molecule interacts with its
target. In order to determine efficacy and safety of new
drugs there is a clear move within the pharmaceutical
industry towards increased emphasis on cell-based
assays. Well-structured methodological studies are use-
ful to understand how highly diluted tinctures work.
Thus we have developed and tested several new highly
diluted tinctures, of which three of them are described
here. As products were coded by an external observer,
they were initially coded as M followed by a number. In
the present study we describe the biological activity of
M1, M2 and M8 both in vitro in immune cells from
mice and human, and in vivo in mice.
Methods
2.1. Combination of highly diluted tinctures
Mother tinctures were produced by Laboratório
Schraibmann Ltda (Carapicuíba - Brazil) which is
authorized by the Brazilian Health Ministry. They cer-
tify high quality, physicochemical composition, and
endotoxin-free conditions of its products. Dilution pro-
cedures have followed standard methodology described
at the Brazilian Homeopathic Pharmacopoeia. In brief,
starting from a whole extract (MT) or initial decimal
dilutions (dH) of several tinctures, the highly diluted
tinctures were obtained by serial decimal dilutions in
distilled water (1 part of tincture to 9 parts of water -
v/v). In between each dilution, the solution was vigor-
ously manual shaken (by hand) with 100 strong vertical
strokes against a soft pad. The resulting aqueous solu-
tion is colorless and odorless, and contains 0.1% alco-
hol. These were stored in the dark at room
temperature. Three complex products were used,
namely M1, M2 and M8. Its composition is described
in table 1 together with the original concentration of
the matrices.
2.2. In vitro determination of M1, M2 and M8 biological
activity on human cell lines
HT29 (ATCC: HTB-38) derived from human colon-rec-
tal cancer, K562 (ATCC: CCL- 243) immortalized mye-
logenous leukemia cells from human, monocytes and
monocytes derived macrophages from human donors
were used in in vitro experiments, that were performed
at 37°C in a humidified 5% CO2 atmosphere for 48
hours. All treatments were administered to log-phase of
growing cells. All solutions used to treat cells were vig-
orously shaken before adding them to cell culture. An
initial dose of 20% (v/v) of highly diluted tinctures was
added to the cells and, after 24 hours, a reinforcement
dose of 1% was added according to a previous standard
treatment protocol [2]. All experiments were performed
at least three times in a blind manner. Data representa-
tive of those experiments (n = 9 for each group) were
submitted to ANOVA and Tukey test to determine sta-
tistical difference (p < 0.05).
2.2.1. Cytotoxicity assays
Apoptosis and necrosis were estimated after treatment.
Immortalized myelogenous leukemia cells from human
K562 were treated with M1, M2 and M8 and percentage
of cell death was determined by flow cytometry.
Annexin V-FITC Apoptosis detection kit (BIOPharmi-
gen) and propidium iodide (PI) were used to evaluate
cell viability and DNA content in cell cycle according to
manufacture instructions.
2.2.2. Cytokines detection
Human white blood cells were isolated from whole-
blood leukoreduction filters obtained after platelet
apheresis. They were donated by healthy volunteers at
the apheresis center from Hospital de Clínicas - UFPR.
These cells were assayed in vitro in order to detect cyto-
kine production after treatment. All related practice was
approved by the Ethical Committee on Human Research
from UFPR.
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The content of leukoreduction chamber was eluted
with PBS, and peripheral blood mononuclear cells
were purified using standard Ficoll-Paque gradient
centrifugation. After monocytes purification, cells were
resuspended in complete RPMI 1640 medium supple-
mented with 2.5 ng/ml rhGM-CSF (PeproTech, Lon-
don, England), and maintained at 37°C, 5% CO2 for 9
days to differentiation into macrophages. Cells were
dislodged with trypsin and then plated (5 × 105 cells/
well in 96-well tissue culture plates) to determine
cytokines release. Macrophages ability to produce
cytokines when challenged with each highly diluted
tinctures, in the presence or not of 5 μg/mL LPS (lipo-
polysaccharide) was determined after 48 hours on
supernatant of cultures using human Th1/Th2 cyto-
kine CBA kit (BD - Pharmingen) according to manu-
facture instructions. Fluorescence was detected by flow
cytometry and cytokine concentration was obtained
comparing data with standards cytokines curve at the
CBA program (BD).
2.2.3. HT29-pNFB-hrGFP reporter cells
Stable transfection with the pNF-B-hrGFP plasmid
(PathDetect signal transduction pathway cis-reporting
systems kit - Stratagene) was performed on HT29
(ATCC: HTB-38) cells. Briefly subconfluent HT29 cells
were transfected with pNF-B-hrGFP plasmid using
Lipofectamine 2000 (Invitrogen) and selected with
hygromycin. After two weeks, cells were stimulated for
24 h with a pro-inflammatory cocktail (25 ng/mL
TNFa-tumor necrosis factor alpha, and 1.25 ng/mL IL-
1b - interleukin 1 beta). GFP (green fluorescent protein)
positive cells were sorted with a MoFlo cell sorter
(Dako, Carpinteria, CA).
The sorted cells were maintained in RPMI (GIBCO)
containing 10% FBS, 1 U/mL penicillin, 1 μg/mL strep-
tomycin at 37°C in a humidified 5% CO2 atmosphere.
For the NF-B (nuclear factor kappa B) activation assay,
exponentially growing HT29 p NF-B-hrGFP cells were
cultured for 48 hours in absence or presence of 3 ng/
mL TNFa with or without M1, M2, or M8 products.
Percentage of positive GFP cells and the viability (using
propidium iodide- PI) were determined using CyAn™
ADP Flow Cytometer (Dako, Carpinteria, CA) and Sum-
mit v4.3 software [4].
2.3. In vivo treatment
2.3.1. Animals
Six to eight weeks old male albino Swiss mice, weighing
30-35 g, were grown and maintained at Central Animal
House from Universidade Federal do Paraná (UFPR).
They were housed at controlled temperature (22 ± 3°C),
12-hours light/dark cycle, and received a standard
laboratory diet. All recommendations from Brazilian
National Law n° 6.638.058, Nov. 1979, for scientific
management of animals were followed. Institutional
Animal Care Committee approved all related practices.
Mice were weight and randomly assembled into four
groups containing 10 animals in each. M1, M2 and M8
lacking one decimal dilution along with distilled water
(control) were kept in distinct 20 mL glasses that were
coded by an external observer. At the moment of treat-
ment, we have added 20 mL into a bottle containing
Table 1 Composition of highly diluted tinctures with initial and final dilution of each element
Components Matrix Final concentration Final concentration (v/v %)
M1* M2* M8*
Aconitum napellus MT 20 dH 20 dH 20 dH 0.1 × 10-19
Arsenicum album 6 dH 18 dH 18 dH 18 dH 0.1 × 10-17
Asa foetida MT 20 dH 20 dH 20 dH 0.1 × 10-19
Calcarea carbonica 8 dH 16 dH 16 dH 16 dH 0.1 × 10-15
Chelidonium majus MT 20 dH 20 dH - 0.1 × 10-19
Cinnamon MT 20 dH 20 dH - 0.1 × 10-19
Conium maculatum 5 dH 17 dH 17 dH 17 dH 0.1 × 10-16
Echinacea purpurea MT 20 dH - - 0.1 × 10-19
Gelsemium sempervirens MT 20 dH - - 0.1 × 10-19
Ipecacuanha 5 dH 13 dH 13 dH 13 dH 0.1 × 10-12
Phosphorus 12 dH 20 dH 20 dH 20 dH 0.1 × 10-19
Rhus toxicodendron 6 dH 17 dH 17 dH 17 dH 0.1 × 10-16
Silicea 12 dH 20 dH 20 dH 20 dH 0.1 × 10-19
Sulphur 12 dH 24 dH 24 dH 24 dH 0.1 × 10-23
Thuja occidentalis 6 dH 19 dH 19 dH 19 dH 0.1 × 10-18
*M1, M2, and M8 were prepared from 15, 13, and 11 components, respectively, in different dilutions. In-between dilutions, the solutions are vigorously shaken by
hand against a soft pad.
de Oliveira et al. BMC Complementary and Alternative Medicine 2011, 11:101
http://www.biomedcentral.com/1472-6882/11/101
Page 3 of 11
180 mL of drinking water. All bottles were vigorously
shaken and offered to mice just before the beginning of
the dark cycle. Each animal has received approximately
10 ml/day for 7 days. Bottles were replaced every day
with new one containing freshly diluted solutions.
2.3.2. Biological activity analysis of M1, M2 and M8 on
mice cells
At the end of the studies animals were killed by cervical
dislocation (n = 9 for each tested group). Macrophages,
lymph nodes, and bone marrow cells were removed as
described elsewhere [2-4]. In brief, macrophages were
harvested from the mice peritoneal cavities with cold
phosphate buffer saline (PBS), pH 7.4, and cells were
counted using a Neubauer chamber. Lymph nodes were
removed from the mesentery, tissue was dissociated
using sterile Medicons (BD), and the cell suspension was
filtered with a 100-μm mesh filter (Falcon, BD). Cells
were pelleted by centrifugation, resuspended in PBS,
incubated in a culture flask with PBS at 37°C in a humidi-
fied atmosphere containing 5% CO2. After incubating for
40 min, non-adherent cells were transferred to sterile
tubes, washed three times with PBS and counted using
an automated cell counter (CELM). Femurs were dis-
sected and cleaned. Epiphyses were removed and the
marrow was flushed with Dulbecco’s Modified Eagles
Medium (DMEM) containing 10% fetal bovine serum
(FBS) with 1 U/ml penicillin, 1 mg/ml streptomycin, and
2.5 mg/ml amphotericin. All cell types were counted and
cell density adjusted depending on the experiment. Cells
were then plated and cultured for each experiment.
2.3.2.1. Cytotoxicity assays The neutral red assay is
based on the initial protocol described by Borenfreund
and Puerner in 1984 [5] and determines the accumulation
of the neutral red dye in the lysosomes of viable, uninjured
cells. Following exposure to highly diluted tinctures
macrophages were incubated for 2 hours with neutral red
dye (10 ug/ml). Cells were then washed, and the ethanolic
dissolution medium was added followed by gentle shaking
for 10 min so that complete dissolution was achieved.
Absorbance at 540 nm was recorded using the microplate
reader (ELx 800, Meridian Diagnostic, Inc).
2.3.2.2. Reactive oxygen and nitrogen species Macro-
phages were subjected to analyses of reactive oxygen spe-
cies (ROS) and nitrogen species production. Anion
superoxide O2
-, hydrogen peroxide (H2O2), and nitric
oxide (NO) were determined on culture supernatant as
described elsewhere [6-8]. Briefly, after in vivo treatment,
mice were killed and macrophages were removed and
cultivated on 96 well plates (5 × 105 cells/well) at 37°C in
a humidified atmosphere containing 5% CO2. After 15
min, non-adherent cells were removed by washing. The
remaining adherent cells, mainly macrophages, were
incubated with the specific reaction solution for each
assay for different periods. Resulting change in
absorbance was determined in a microplate reader (ELx
800, Meridian Diagnostic, Inc). Proper standard concen-
tration curves and positive controls were also done
according to previous published methodology [6-8].
2.3.2.3. Lipid peroxidation and immunophenotyping
of bone marrow cells Bone marrow cells were collected
from femurs and immunophenotyped using a mouse
lineage panel as described elsewhere [3]. In brief, one
million cells per group were fixed with 1% paraformal-
dehyde, washed, and incubated with 0.5 μg/ml biotiny-
lated antibody listed below, in PBS for 40 minutes. They
were then washed with PBS and incubated with 0.5 μg/
ml phycoerythrin (PE) labeled secondary antibody in
PBS for 30 minutes. Fluorescence was analyzed accord-
ing to standard procedures using a FACSCalibur flow
cytometer.
Lipid peroxidation was determined according to Nour-
ooz-Zadeh and colleagues in 1994 [9]. Briefly, ten mil-
lion bone marrow cells were homogenized in methanol,
centrifuged and incubated for 30 minutes with 10 mM
triphenylphosphine (TPP) solution. After cells were
incubated with FOX2 (100 μM xylenol orange, 400 mM
butylated hydroxytoluene, 25 mM sulfuric acid and
ammonium ferrous sulphate in 90% methanol was
added and incubated at RT for 30 min. Absorbance was
determined on a spectrophotometer at 560 nm. Data
was obtained compared to standard curve.
2.3.2.4. Immunophenotyping of lymph nodes cells
Lymph node cells were isolated as described above. Cells
(106 cells/sample) were incubated with anti-CD3/FITC and
anti-CD4/PE, anti-CD8/PE, anti-CD19/PE or Pan-NK/PE
(BD Pharmingen) antibodies in PBS/1%FBS for 30 min,
and washed three times with PBS. Results were obtained by
flow cytometry using CellQuest software (BD) [4].
2.4. Statistical analysis
All in vitro and in vivo experiments were performed at
least three times in triplicate, and data analysis was per-
formed in a double-blinded manner. All data generated
were submitted to analysis of variance (ANOVA) and
Tukey test. ANOVA is a statistical test that search for a
difference across groups as a whole. If there is a statisti-
cally significant difference across means then a multiple
comparison method should be used to try to find speci-
fic differences between pairs of groups. In this case we
have used Tukey test to determine the statistical signifi-
cance of the intergroup comparisons (p < 0.05).
3. Results
3.1. Determination of in vitro M1, M2 and M8 biological
activity on cytotoxicity, cell cycle, cytokine production,
and NF-B activation
Annexin V is often used to study the translocation of
phosphatidylserine (PS) from the inner leaflet of the
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plasma membrane to the outer leaflet in apoptotic cells.
It is a simple and effective method to detect apoptosis
at even very early stages [10]. Propidium iodide (PI)
intercalates into double-stranded nucleic acids. It is
excluded by viable cells but can penetrate cell mem-
branes of dying or dead cells. Thus double-labeling with
annexin V and PI could be used to differentiate between
different types of cell death. The neutral red assay is
used to measure cell viability, as living cells take up the
neutral red, which is concentrated within the lysosomes
of cells [11]. We have observed a tendency of cell death
after M8 treatment on HT-29 reporter cell line after sta-
tistical analyses at p < 0.05 level (Figure 1A). None of
the highly diluted tinctures tested were cytotoxic to
macrophages (data not shown), and K562 (Figure 1B).
Results also demonstrated that M1, M2, and M8 have
no effects on cell cycle (Figure 1B). Although M8
induced cell death on HT-29 cells all other cells tested
were not affected by M8, including B16F10 cells [4].
Human monocytes were differentiated into macro-
phages and treated with M1, M2, and M8 in the
presence or absence of LPS. There was no change in
cytokines release with treatment alone. LPS-stimulated
macrophages treated with M1, and M8 presented a
decrease in interferon-g (IFN-g) production, and M1,
M2, and M8 a decrease in tumor necrosis factor-a
(TNF-a) release (Figure 2A and 2B).
HT29-pNF-B-hrGFP reporter cells were used to
determine NF-B after treatment. We have observed
that only M1 has decreased NF-B activity on TNF-a
stimulated HT29-pNF-B-hrGFP cells (Figure 2C). Thus
we have tested in vitro different M1 concentrations (10,
20, ad 30%) and they all presented the same effect on
NF-B activity (data not shown).
3.2 Biological activity of in vivo administration of M1, M2
and M8 to mice
Macrophages, bone marrow and lymph node cells from
mice were analyzed after 7 days treatment. All treat-
ments have decreased the levels of superoxide anion O2
-
and hydrogen peroxide (H2O2) release by macrophages
(Figure 3A and 3B). NO was found to be increased after
 
* 
Figure 1 Effects of treatments on HT-29 and K562 cells viability and cell cycle. Apoptosis and necrosis were estimated after treatment.
HT29-pNF-B-hrGFP reporter cells HT29 (Fig A) and immortalized myelogenous leukemia cells from human K562 (Fig B) and were treated with
M1, M2 and M8 and percentage of cell death was determined by flow cytometry. Annexin V-FITC Apoptosis detection kit (BIOPharmigen) and
propidium iodide (PI) were used to evaluate cell viability and DNA content in cell cycle. ANOVA and Tukey test were use to determine statistical
differences. Neither highly diluted compound were cytotoxic nor have effects on cell cycle. *p < 0.05
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M1 and M8 treatments (Figure 3C). We have observed
lipid peroxidation on bone marrow cells induced by M1
and M2 (Figure 4G).
A mouse lineage panel was used to immunophenotype
bone marrow cells (CD11b (Mac-1)-monocytes/macro-
phages, Ly-6G-granulocytes, CD45R-B lymphocytes,
CD11c-dendritic cells, CD3-T lymphocytes, and TER-
119-erythrocytes), as well to lymph node cells (CD11b-
Monocytes/macrophages, CD3-T lymphocytes, CD4-T
helper lymphocytes, CD8-T cytotoxic lymphocytes,
CD19-B lymphocytes, PanNK (DX5)-NK lymphocytes).
Immunophenotyping of bone marrow (Figure 4A-F) and
lymph node cells (Figure 5A-C) showed that each com-
position of highly diluted tinctures presented a different
pattern of host immune response. M1 has increased
monocytes/macrophages and B lymphocytes in bone
marrow and lymph nodes. CD3 lymphocytes and granu-
locytes were increased and erythrocytes were decreased
in bone marrow. M2 has increased monocytes/macro-
phages and granulocytes and decreased B lymphocytes
as well as erythrocytes in bone marrow. And M8 has
increased B lymphocytes in bone marrow. Lymph nodes
T cytotoxic lymphocytes were increased in lymph nodes
by all treatments. Table 2 summarizes the biological
activity analysis of M1, M2 and M8 on mice cells.
Discussion
Plant extracts are common subjects of basic research.
For instance, imunopharmacological potential of Thuya
occidentalis was widely demonstrated both in vivo and
Figure 2 Cytokine production and NF-B activation assay after M1, M2, and M8 treatment. Fig A - Human monocytes were isolated and
differentiated into macrophages. Macrophages ability to produce interferon-g (IFNg) and tumor necrosis factor (TNF-a) when challenged with
each highly diluted tincture, in the presence or not of 5 μg/mL LPS was determined after 48 hours on supernatant of cultures using CBA.
Fluorescence was detected by flow cytometry, and ANOVA and Tukey test were use to determine statistical differences.*LPS-induced
macrophages decreased IFN production after M1 and M8 treament and TNF-a release was decreased by all medications. Fig B - Exponentially
growing HT29 p NF-B-hrGFP cells were cultured for 48 hours in absence or presence of 3 ng/mL TNFa with or without M1, M2, or M8 highly
diluted tinctures. Percentage of positive GFP cells was determined by flow cytometery. M1 treatment after TNF stimulation has decreased NF-B
activity, and different concentrations of M1 had the same effects. *p < 0.05
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in vitro as reviewed by Naser and colleagues in 2005
[12]. Highly diluted tinctures or substances are less stu-
died, but there is an increased interest in these type of
formulations due to its low cost and biological effective-
ness. Bellavite and col. revised in 2006 [13] articles con-
taining basic research on cells of the immune system
and inflammation. They have shown that there are few
and rather small groups working on laboratory models,
although evidences of the biological activity in vitro of
highly diluted-dynamized solutions is slowly accumulat-
ing. Our group has tested some highly diluted tinctures
alone and we have found that they present different
responses when different potencies are tested (data not
published yet). Here we have investigated the effects of
three combinations, namely M1, M2, and M8 on mice
and human cells. M1, M2, and M8 are prepared from
15, 13, and 11 highly diluted components, respectively,
in different dilutions as seen on table 1. We have
observed that all these induced different effects on cells,
as well as different immune response type, even though
they have some similarity on its composition as seen on
table 1.
In order to evaluate M1, M2 and M8 safety we have
first determined cell viability and cell cycle after in vitro
treatment. We have used K562, HT-29 cell line and
macrophages to determine if treatment could induce
Figure 3 ROS and NO production by macrophages after treatment. Macrophages were subjected to analyses of reactive oxygen species
(ROS) and nitrogen species production. Macrophages were incubated with the specific reaction solution for each assay for different periods.
Resulting change in absorbance was determined in a microplate reader. Proper standard concentration curves and positive controls were also
done. ANOVA and Tukey test were use to determine statistical differences. We have found that the levels of superoxide anion (O2
-) and
hydrogen peroxide (H2O2) release after all treatments have decreased. NO was found to be increased after M1 and M8 treatments. *p < 0.05
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Figure 4 Immunophenotyping and lipid peroxidation of mice bone marrow cells. Mice were treated for 7 days, femurs were removed and
bone marrow cells were collected. Cells were immunophenotyped using a mouse lineage panel (Fig A-F). Fluorescence was analyzed using flow
cytometry and data were analyzed with a Cell Quest program (BD). ANOVA and Tukey test were use to determine statistical differences.
Treatment with all highly diluted tinctures changed the expression profile of bone marrow cell markers. Lipid peroxidation was determined by
FOX2 absorbance on a spectrophotometer at 560 nm (Fig G). Data was obtained compared to standard curve. We have observed lipid
peroxidation on bone marrow cells induced by M1 and M2. *p < 0.05
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cell death and/or changes in cell cycle. We have
observed that none of the tested combinations of highly
diluted tinctures were cytotoxic or affected cell cycle.
Next we sought to determine if there was any effect of
these highly diluted tinctures on cytokine release by
monocytes-derived macrophages. Treatment alone did
not change cytokines production by cells, but when cells
were stimulated with LPS and then treated IFN-g and
TNF-a production was decreased. TNF-a is an
important inflammatory factor that acts as a master
switch in establishing an intricate link between inflam-
mation and cancer. TNF-a secretion can be induced by
conserved structural elements common to microbial
pathogens as well as by tumour cells. Several studies
have focused on the transcriptional regulation of TNF-a
looking at transcription factors that bind to the respon-
sive element sites within the TNF-a promoter. NF-B is
a transcription factor that plays crucial roles in
Table 2 Summary of the biological activity analysis of M1, M2 and M8 on mice cells.
Macrophages Bone marrow cells Lymph node cells General comments
O2
- H2O2 NO Lipid peroxidation Immunophenotyping* Immunophenotyping




*Detection of changes in cell markers on bone marrow cells after treatment. + Detection of specific cell markers on lymph node cells. Grey arrow - decrease in
production or detection; black arrow - increase in production or detection; O2
- - superoxide anion; H2O2 - hydrogen peroxide; NO - nitric oxide.
Figure 5 Immunophenotyping of mice lymph node cells. Lymph node cells were isolated and immunophenotyped. Results were obtained
by flow cytometry using CellQuest software (BD). ANOVA and Tukey test were use to determine statistical differences. Treatment with all highly
diluted tinctures has changed the expression profile of lymph node cell markers. *p < 0.0
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inflammation and immunity [14]. Many proinflamma-
tory stimuli can activate NF-B, mainly through IKK-
dependent phosphorylation and degradation of the IB
inhibitory proteins. When NF-B translocates to the
nucleus, it activates the transcription of target genes,
including cytokines like TNF-a, chemokines, and antia-
poptotic factors [15]. We have used a reporter cell line
to find out if M1, M2, and M8 in the presence or
absence of TNF-a stimulus, have any effect on NF-B
activity. The reporter cell line HT29-pNF-B-hrGFP is
routinely used to screen natural or synthetic compounds
that interfere and/or modulate NF-B activity. We have
observed that only M1 has decreased NF-B activity but
it was not downregulated by M2 and M8. However we
have observed TNF-a reduction by these highly diluted
tinctures. NF-B, C/EBPb, Ets, NF-AT, activating pro-
tein 1 (AP-1), cAMP response element-binding protein,
signal transducers and activators of transcription
(STAT1), and lipopolysaccharide (LPS)-induced TNF-a
factor (LITAF) were all implicated on regulating TNF-a
transcription [16]. Regulatory elements in transcriptional
activation of the TNF-a gene are not completely under-
stood. Further investigation of others transcription fac-
tors that regulate TNF-a induction may be conducted
in order to investigate the relative contributions of these
various regulatory elements in transcriptional decrease
of the TNF-a by M2 and M8. Improving the efficacies
of anti-inflammatory mediators hold promises for the
therapy of cancers and chronic inflammatory disorders.
Thus after detecting that M1, M2, and M8 have in vitro
effects we have established the biological activity of
those highly diluted tinctures after mice treatment (in
vivo).
First we have detected changes on oxidative metabo-
lism of macrophages after M1, M2, and M8 in vivo
administration to mice. The phagocytic oxidative burst
is a primary effector of innate immunity that protects
against infection. When triggered by a phagocytic stimu-
lus or certain membrane-active agents, macrophages
activated in vivo or in vitro undergo a respiratory burst
that is characterized by the production of high levels of
oxygen metabolites. The NADPH-dependent oxidase
(Phox), which produces superoxide, assembles in the
phagosomal membrane [17]. Activated macrophages
also produce nitric oxide (NO), generated from arginine
and oxygen by the inducible nitric oxide synthase
(iNOS) [18]. Nitric oxide is a cytotoxic product of acti-
vated macrophages, along with reactive oxygen species
that have been shown to be involved in numerous regu-
latory functions [19]. Reactive oxygen species have been
increasingly implicated as playing a central role in the
pathophysiology of clinical infections. More specifically
superoxide, hydrogen peroxide, and recently, nitric
oxide are thought to contribute to these processes. As
these highly diluted tinctures exhibit the ability to mod-
ulate the respiratory burst and NO production they
could be useful adjutants to host defence and to micro-
bicidal activity [20].
4-Hydroxynonenal (4-HNE) is a product derived from
lipid peroxidation that can affect several mechanisms on
the cell depending on its concentration. Low levels were
shown to induce cell differentiation, even though the
exact mechanism of action is still not known [21,22]. In
fact, previous results from our lab have shown that
highly diluted tinctures act on bone marrow cells stimu-
lating proliferation and differentiation [3]. Thus this
might account as one the mechanism of action by how
highly diluted tinctures stimulate bone marrow cells
proliferation and differentiation, but further experiments
are needed.
Bone marrow is a special, spongy, fatty tissue that
houses stem cells, located inside a few large bones.
These stem cells transform themselves into leukocytes,
red blood cells and platelets, essential for immunity and
circulation. A mouse lineage panel to bone marrow cells
was used (CD11b (Mac-1)-monocytes/macrophages, Ly-
6G-granulocytes, CD45R-B lymphocytes, CD11c-dendri-
tic cells, CD3-T lymphocytes, and TER-119-erythro-
cytes), as well to lymph node cells (CD11b-Monocytes/
macrophages, CD3-T lymphocytes, CD4-T helper lym-
phocytes, CD8-T cytotoxic lymphocytes, CD19-B lym-
phocytes, PanNK (DX5)-NK lymphocytes). We found
that each highly diluted tincture presented a different
pattern of host immune response. M1 has increased
monocytes/macrophages and B lymphocytes in bone
marrow and lymph nodes. CD3 lymphocytes and granu-
locytes were increased and erythrocytes were decreased
in bone marrow. M2 has increased monocytes/macro-
phages and granulocytes and decreased B lymphocytes
as well as erythrocytes in bone marrow. And M8 has
increased B lymphocytes in bone marrow. Lymph nodes
T cytotoxic lymphocytes were increased in lymph nodes
by all treatments. Table 2 summarizes the biological
activity analysis of M1, M2 and M8 in vivo.
The analysis of highly diluted tinctures after mice
treatment showed that M1, M2, and M8 improved the
innate (cellular) immunity. In addition, M1 also aug-
mented acquired (humoral) immunity. M2 was the only
highly diluted compound that diminished B lymphocytes
precursors, which produce antibodies, responsible to
humoral immunity. Decrease in antibody production by
M2, but without causing immune suppression since it
has increased the number of cytotoxic cells, turns out to
be interesting to autoimmune diseases where this type
of response is extremely important. The results from
M8 treatment, as it increases innate immunity and does
not alter acquired immunity, suggest a possible use in
diseases where antibody production is irrelevant, i.e.
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viruses where the pathogenic agent is extremely muta-
ble. As for M1 treatment we can conclude that it shows
a possible general action on immune system, enhancing
both innate and acquired immunity which are important
in several diseases including some types of cancers.
Conclusions
Based on the results presented here, these highly diluted
tinctures were shown to modulate immune responses.
Even though further investigation is needed there is an
indication that these combinations of highly diluted
tinctures could be used as therapeutic interventions in
disorders where the immune system is compromised. It
could be reasonably expected that, in the years to come,
there will be a steady growth in the use of highly diluted
tinctures as they often present no risk of serious side-
effects because of their low toxicity and they are effica-
cious therapeutic interventions.
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